Stockreport

TriSalus Reports Q3 2024 Financial Results and Provides Business Update [Yahoo! Finance]

TriSalus Life Sciences, Inc.  (TLSI) 
PDF – Provided 2025 guidance with expectations of over 50% annual sales growth, 20%+ reduction in operating expenses, positive full-year EBITDA, and positive cash flow in H [Read more]